Investors in Devices

Vivalto Partners is an independent European management company approved by the Autorité des Marchés Financiers, specializing in investment in the healthcare sector. We invest in profitable SMEs and mid-cap companies and support their managers in their development projects, in capital and through strategic and operational support. Founded in 2021 by Daniel Caille, a pioneering figure in private healthcare in France, Vivalto Partners brings together healthcare experts and investment professionals in an approach to supporting players who contribute to the quality of care to meet the major challenges of transforming the sector in Europe.

GT Ventures is an international firm specializing in emerging technology sectors. With a global reach and local presence in key regions, we identify and fund high-growth technology companies. Our expertise lies in combining capital with emerging technology,Growth tech ventures was formed in 2019

Itera Invest is an investment firm focused on supporting the growth and development of promising businesses in France. Specializing in private equity and venture capital investments, Itera Invest partners with entrepreneurs and management teams to provide strategic capital and operational support. The firm emphasizes a hands-on approach, leveraging its expertise and network to drive sustainable growth and maximize value creation. Itera Invest's investment strategy spans across various sectors, with a commitment to nurturing innovation and entrepreneurship. By fostering strong partnerships and offering tailored financial solutions, Itera Invest aims to empower companies to achieve their full potential and become market leaders in their respective industries.

Praetura are a venture capital firm in the North West, who invest in early-stage businesses and provide 'more than money' support. We have developed a reputation for being a supportive and proactive investor who injects more than just capital. We can evidence the value from our differentiated approach from both investment returns and testament from our portfolio companies. Our partnered entrepreneurs embrace the shoulder to shoulder Praetura approach and utilise our experience and resource to maximise their businesses’ potential.

Creathor Ventures invests in technology-oriented companies that drive the automation of industry and business, and the personalization and digitalization of healthcare. The regional focus is on Germany and Switzerland. From its locations in Bad Homburg and Zurich, the team currently supports over 30 tech and healthcare companies. Over the past 30 years, the management team has financed over 200 companies as lead or co-lead investors. More than 20 companies have been listed on international stock exchanges. Creathor Ventures currently manages a fund volume of over 230 million euros.

Fountain Healthcare Partners is a life science venture capital firm based in Dublin Ireland with an office in New York. Fountain currently manages over €300M and is actively investing its third fund raised in 2019. The team at Fountain originally worked within the corporate VC group at Elan Corporation and raised its first independent fund in 2008. Fountain invests in drugs, devices and diagnostics with a focus on companies developing innovative products that address unmet medical needs and deliver significant pharmacoeconomic benefits.

Bullnet Capital operates as an independent Venture Capital firm, specializing in investments in high technology startups originating and based in Spain. The firm targets companies with proprietary and innovative technologies within the IT sector or closely related fields such as enterprise software, electronics, photonics, laser technology, medical devices, and scientific instrumentation. Known for its hands-on approach, Bullnet Capital actively engages in the management of its portfolio companies, positioning itself as a strategic partner to founders from the outset rather than solely providing financial support. This approach underscores their commitment to fostering growth and success in their investments.